Filing Details

Accession Number:
0001209191-21-067892
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-03 17:10:39
Reporting Period:
2021-11-01
Accepted Time:
2021-12-03 17:10:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1087294 Cumberland Pharmaceuticals Inc CPIX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1684087 Caroline Young 2525 West End Avenue
Suite 950
Nashville TN 37203
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-01 15 $2.67 14,003 No 4 P Direct
Common Stock Acquisiton 2021-11-02 15 $2.63 14,018 No 4 P Direct
Common Stock Acquisiton 2021-11-03 15 $2.71 14,033 No 4 P Direct
Common Stock Acquisiton 2021-11-04 15 $2.73 14,048 No 4 P Direct
Common Stock Acquisiton 2021-11-05 15 $2.71 14,063 No 4 P Direct
Common Stock Acquisiton 2021-11-08 15 $2.95 14,078 No 4 P Direct
Common Stock Acquisiton 2021-11-09 15 $3.21 14,093 No 4 P Direct
Common Stock Acquisiton 2021-11-10 15 $2.94 14,108 No 4 P Direct
Common Stock Acquisiton 2021-11-11 15 $2.83 14,123 No 4 P Direct
Common Stock Acquisiton 2021-11-12 15 $2.67 14,138 No 4 P Direct
Common Stock Acquisiton 2021-11-15 15 $2.71 14,153 No 4 P Direct
Common Stock Acquisiton 2021-11-16 15 $2.66 14,168 No 4 P Direct
Common Stock Acquisiton 2021-11-17 15 $2.58 14,183 No 4 P Direct
Common Stock Acquisiton 2021-11-18 15 $2.58 14,198 No 4 P Direct
Common Stock Acquisiton 2021-11-19 15 $2.55 14,213 No 4 P Direct
Common Stock Acquisiton 2021-11-22 15 $2.35 14,228 No 4 P Direct
Common Stock Acquisiton 2021-11-23 15 $2.29 14,243 No 4 P Direct
Common Stock Acquisiton 2021-11-24 35 $2.31 14,278 No 4 P Direct
Common Stock Acquisiton 2021-11-26 35 $2.26 14,313 No 4 P Direct
Common Stock Acquisiton 2021-11-29 35 $2.23 14,348 No 4 P Direct
Common Stock Acquisiton 2021-11-30 35 $4.61 14,383 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.